Investing

ClearPoint Neuro : CLPT

CLPT

Stock Data

$15.18

$0.28 (1.88%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

ClearPoint Neuro, Inc. is a pioneering medical device company based in Solana Beach, California, specializing in minimally invasive brain surgeries. With a focus on innovation, it offers the ClearPoint system, a groundbreaking platform that allows for precise surgical procedures in the brain, such as electrode insertion, biopsies, and targeted therapy delivery, all under real-time MRI guidance. The company, which evolved from MRI Interventions, Inc. in 2020, collaborates with notable entities like Philips and the University of California, San Francisco to advance neurological care.

Latest Activity

CLPTClearPoint Neuro, Inc.

Q2 2026

Aug 3, 4:05pm ET

EPS

-$0.38

est -$0.29-32.5%

Revenue

$11M

est $13M-14.6%

ClearPoint Neuro's pivot toward drug delivery readiness ahead of 2027 partner approvals now runs on a tighter clock: cash fell to $29.4 million from $45.9 million at the start of the year. The company also cut full-year 2026 revenue guidance to $48 million to $52 million and missed expectations on both lines as the IRRAS integration lifted operating expenses.

Loading…

ShareRead more

All ClearPoint Neuro Articles

2 Articles

Lee Jackson | May 8, 2026 at 8:06 AM EDT

Here Are Friday’s Top Wall Street Analyst Research Calls: Applied Materials, Devon Energy, Epam Systems, HubSpot, Nike, Shake Shack, Tapestry, Qualcomm, and More

Pre-Market Stock Futures: Futures are trading higher as we get set to end what has been one of the wildest…

Rich Duprey | Jul 10, 2025 at 10:54 AM EDT

Move Over, Magnificent 7: The Frontier 7 Will Redefine Our Future

Investors have become quite familiar with the Magnificent Seven, the group of tech giants that reshaped markets with their dominance…